http://www.healio.com/infectious-disease/influenza/news/online/%7Bca1d64f4-092e-4260-a801-cef96d41fd0d%7D/no-benefit-seen-with-iv-peramivir-in-hospitalized-patients-with-influenza
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment